An adolescent with rhabdomyosarcoma during pregnancy

Tumori

Volumn 94, Issue 3, 2008, Pages 431-433

  Meazza, Cristina ^a   Casanova, Michela ^a   Zaffignani, Elena ^a   Clerici, Carlo Alfredo ^a   Favini, Francesca ^a   Vasquez, Roberto ^a   Ferrari, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Chemotherapy; Pregnancy; Rhabdomyosarcoma

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; NAVELBINE; VINCRISTINE;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADOLESCENT PREGNANCY; ARTICLE; BLOOD TESTIS BARRIER; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CASE REPORT; CESAREAN SECTION; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOHYDRAMNIOS; PHYSICAL EXAMINATION; RHABDOMYOSARCOMA; THERAPEUTIC ABORTION; TREATMENT REFUSAL; TUMOR BIOPSY; TUMOR VOLUME;

EID: 48249112241     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400324     Document Type: Article

References (12)

1. Donegan Wl: Cancer and pregnancy. CA Cancer J Clin, 33: 194-214, 1983.
2. Bisogno G, Ferrari A, Bergeron C, Scagnellato A, Prete A, Alaggio R, Casanova M, D'Angelo P, Di Cataldo A, Carli M: The IVADo regimen: a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma. Cancer, 103: 1719-1724, 2005.
3. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (Eds): Cancer Incidence and survival among children and adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program, NIH Pub. No. 99-4649, Bethesda, MD, 1999.
4. Crist W, Anderson J, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS: Intergroup Rhabdomyosarcoma Study-IV: results for patients with non-metastatic disease. J Clin Oncol, 19: 3091-3102, 2001.
5. Doll RC, Ringenberg QS, Yarbo JW: Antineoplastic agents and pregnancy. Semin Oncol, 16: 337-345, 1989.
6. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G: Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med, 152: 573-576, 1992.
7. Cardonick E, Iacobucci A: Use of chemotherapy during human pregnancy. Lancet, 5: 283-291, 2004.
8. Sorosky JL, Sood AK, Buekers TE: The use of chemothera-peutic agents during pregnancy. Obstet Gynecol Clin North Am, 24: 591-599, 1997.
9. Buekers TE, Thomas L: Chemotherapy in pregnancy. Obstet Gynecol, 25: 323-327, 1998
10. Ebert U, Loffler H, Kirch W: Cytotoxic therapy and pregnancy. Pharmacol Ther, 74: 207-220, 1997.
11. Peres RM, Sanseverino MT, Guimaraes JL, CoserV, Giuliani L, Moreika RK, Ornsten T, Schuller-Faccini L: Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy. A multicenter study. Braz J Med Biol Res, 34: 1551-1559, 2001.
12. Martin D, Winter SS, Gardner MO, Nicklaus P: Rhabdomyosarcoma treated with chemotherapy during the third trimester. Obstet Gynecol, 89: 828-831, 1997.